TrialBMJ open2022

Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial.

Tjarda M Boere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.